ArticleEndocrine journal2025

A real-world disproportionality analysis of tirzepatide-related adverse events based on the FDA Adverse Event Reporting System (FAERS) database.

Jie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.